MedPath

IPX-159

Generic Name
IPX-159

Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)

Phase 2
Completed
Conditions
Restless Legs Syndrome
Interventions
Drug: Placebo
First Posted Date
2012-01-31
Last Posted Date
2017-02-01
Lead Sponsor
Impax Laboratories, LLC
Target Recruit Count
159
Registration Number
NCT01521663
Locations
🇺🇸

University of Alabama at Birmingham, Brimingham, Alabama, United States

🇺🇸

Preferred Research Partners, Inc., Little Rock, Arkansas, United States

🇺🇸

Scripps Clinic, La Jolla, California, United States

and more 34 locations
© Copyright 2025. All Rights Reserved by MedPath